Cologuard® first.
Colonoscopy as needed.

For average-risk patients 45 and older.


Your trusted noninvasive test just got better. Now you can get more eligible patients screened with enhanced performance.1,2

How To Order
Sign Up

Dr Vega and Belinda Khou have been compensated for sharing their expertise and for acting as consultants for Exact Sciences.

optimize your experience
Which colorectal cancer (CRC) screening option do you prescribe most often to your average-risk patients?
Your most prescribed CRC screening option:
Change Answer
Dr Chuck Vega, MD, and his quote about the performance of the Cologuard Plus™ test.

The Cologuard Plus™ test


The latest innovation from Exact Sciences: the Cologuard Plus test was designed for higher specificity without compromising sensitivity.1,3
View The Data

Learn how screening with the Cologuard Plus test can detect and help prevent CRC through follow-up colonoscopy4-7

See The Benefits

Find out about high patient adherence with the Cologuard test8

Explore Adherence

No. To ensure access to noninvasive CRC screening, both tests will still be available. This way, Exact Sciences can maintain broad coverage.1 As the Cologuard Plus test is on the market for a longer period, more insurers will begin to cover it. Until then, eligible patients whose insurance does not cover the Cologuard Plus test will still receive best-in-class noninvasive CRC screening with the Cologuard test.2,3

  • 1 Data on file for coverage. Market Access. 2024. Exact Sciences Corporation. Madison, WI.
  • 2 Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-1297.
  • 3 Cologuard® Clinician Brochure. Madison, WI: Exact Sciences Corporation.

Learn More About Cologuard Coverage